Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

6 cancer information nl prostate
Clinical Trials (PDQ®) - National Cancer Institute
Smith JA: Estimated impact of the Prostate Cancer Prevention Trial on population mortalitycommentary. Urol Oncol 23 (6): 463, 2005.

European Urology Supplements : Expert Opinion on Optimal
Expert Report on Optimising Hormonal Control in Prostate Cancer .. Urology 2004;64(6):1177â“81. Corresponding Author Contact Information

Prostate Cancer Screening Attitudes and Continuing Education Needs
A survey questionnaire was used to collect information. on prostate cancer screening among primary care physicians. practicing in Newfoundland and Labrador.

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in
TMPRSS2 Fusions with Oncogenic ETS Factors in Prostate Cancer Involve Unbalanced C. L. Smith, G. E. Ayala, M. M. Ittmann, and N. L. Weigel (2006) Cancer

Casodex (bicalutamide) - Prostate Cancer Treatment Information for
Casodex.net provides information on prostate cancer treatment, Prostatic Cancer Group study no 6 (SPCG-6) of the Early Prostate Cancer Programme

Prostate Cancer References - Prostate Cancer Health Information
Keating NL, O'Malley AJ, Smith MR. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol.

Energy Restriction in Childhood and Adolescence and Risk of
Study on Diet and Cancer. Information on diet and risk factors was collected by unimaas.nl). Prostate cancer is the second most commonly diagnosed

Project: Patient involvement in prostate cancer treatment
Preliminary: Development of patient information material on prostate cancer, in particular the likelihood and nature of side-effects and complications.

Project: Generation and characterization of mouse prostate cancer
entire www.onderzoekinformatie.nl site. fuzzy match The proposed prostate cancer models will reveal important information on the mechanisms underlying

2007 HRC Schedule - Prostate Cancer Foundation
Prostate Cancer Foundation Newsletter New York (NL) vs. Detroit, 7-8, 2. Oakland vs. San Francisco, 6-0, 2. Philadelphia vs. Kansas City, 4-0, 0

2006 Home Run Challenge Game Schedule - Prostate Cancer Foundation
A schedule for the games played during the Prostate Cancer Foundation's 2006 Home Run Minnesota vs. Seattle. 9-10, 6. New York (NL) vs. Los Angeles (NL)


6 cancer information nl prostate
advanced prostate cancer life expectancy
alternative cancer cure prostate
adderall prostate
cancer dean ornish prostate